A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma

University Hospital Geelong, Geelong

Icon Cancer Center, South Brisbane

Greenslopes Private Hospital, Greenslopes

Gold Coast University Hospital, Southport

Queen Elizabeth Hospital, Woodville South

Fiona Stanley Hospital, Murdoch

Vseobecna fakultni nemocnice v Praze, Prague

Charite Universitaetsmedizin Berlin, Berlin

Universita di Torino, Torino

CHU de Marseille - Hopital de la Timone, Marseille

Hospital Universitario A Coruna, A Coruña

IRCCS Azienda Ospedaliera Universitaria San Martino IST, Genova

Karolinska Universitetssjukhuset, Solna

Onkologikoa, Donostia / San Sebastian

Istituto Europeo di Oncologia, Milan

CHU Dijon - Hôpital Mitterrand, Dijon

Elbe Kliniken, Buxtehude

Inova Health Care Services, Falls Church

CHRU Besançon - Jean Minjoz, Rouen

ASST degli Spedali Civili di Brescia, Brescia

Hospital General Universitario Gregorio Maranon, Madrid

Hospital Universitario Ramon y Cajal, Madrid

Medizinische Hochschule Hannover - Klinik for Dermatologie, Allergologie und Venerologie, Hannover

University of Florida Health Cancer Center - Orlando Health, Orlando

Mount Sinai Medical Center of Florida, Inc., Miami Beach

Istituto Oncologico Veneto-I.R.C.C.S., Padua

University of Alabama at Birmingham (UAB), Birmingham

CHU de Grenoble, La Tronche

Hospital Universitario Virgen Macarena, Seville

Azienda Ospedaliero-Universitaria di Modena, Modena

The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James), Columbus

The Cleveland Clinic Foundation, Cleveland

University of Cincinnati Health, Cincinnati

Consorci Hospital General Universitari de Valencia, Valencia

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola

Azienda Ospedaliero Universitaria Senese, Siena

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz

Azienda Ospedaliero Universitaria Pisana, Pisa

CHRU de Lille - Hôpital Claude Huriez, Lille

CHU - Clermont Ferrand, Clermont-Ferrand

Universitaetsklinikum Heidelberg Universitaets-Hautklinik, Heidelberg

Centre Leon Berard, Lyon

Centre Hospitalier Lyon Sud, Pierre-Bénite

Azienda Ospedale Policlinico di Bari, Bari

Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari, Bari

Universität Tübingen, Tübingen

Hopital Saint Louis, Paris

CHU Hopitaux de Rouen, Rouen

MD Anderson Cancer Center, Houston

CHU Amiens Picardie - Hopital Sud, Amiens

"Istituto Nazionale di Tumori IRCCS Fondazione Sen. G. Pascale", Napoli

Banner MD Anderson Cancer Center, Gilbert

Cancer Treatment Centers of America (CTCA) - Western Regional Medical Center, Scottsdale

Klinikum Augsburg, Augsburg

University of Southern California, Los Angeles

University of California, Los Angeles (UCLA), Los Angeles

University of California, San Diego (UCSD) - Moores Cancer Center, San Diego

Universitatsklinikum Regensburg, Regensburg

Stanford Cancer Center, Stanford

Institut Gustave Roussy, Villejuif

Sutter Health Sacramento, Sacramento

Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Universität Würzburg, Würzburg

The Valley Hospital, Ridgewood

Tom Baker Cancer Centre, Calgary

Alberta Health Services Cross Cancer Institute, Edmonton

Princess Margaret Hopsital, Toronto

Fakultni nemocnice Olomouc - Oncology clinic, Olomouc

Dermatovenerologika Klinika, Prague

Fondazione Policlinico Universitario A. Gemelli - Universita Cattolica del Sacro Cuore, Rome

Leids Universitair Medisch Centrum, Leiden

Universitair Medisch Centrum Utrecht, Utrecht

Hospital Germans Trias i Pujol, Badalona

Hospital Universitari Quiron Dexeus Barcelona, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

Hospital Clinic Barcelona, Barcelona

Skånes Universitetssjukhus i Lund, Lund

Centrallasarettet i Växjö, Vaxjo

Bristol Haematology and Oncology Centre, Bristol

Guy's Hospital, London

Royal Marsden Foundation Trust, London